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Abstract.  The lateral diffusion coefficients of various 
epidermal growth factor (EGF) receptor mutants with 
increasing deletions in their carboxy-terminal cytoplas- 
mic domain were compared.  A  full size cDNA con- 
struct of human EGF receptor and different deletion 
constructs were expressed in monkey COS cells.  The 
"EGF receptor mutants expressed on the cell surface of 
the COS cells were labeled with rhodamine-EGF, and 
the lateral diffusion coefficients of the labeled recep- 
tors were determined by the fluorescence photo- 
bleaching recovery method. 
The lateral mobilities of three deletion mutants,  in- 
cluding a mutant that has only nine amino acids in the 
cytoplasmic domain, are all similar (D =  1.5  ×  10  -1° 
cm2/s) to the lateral mobility of the "wild-type" recep- 
tor, which possesses 542 cytoplasmic amino acids.  It 
is concluded that most of the cytoplasmic domain of 
EGF receptor, including its intrinsic protein kinase ac- 
tivity and phosphorylation state, are not required for 
the restriction of its lateral mobility. 
E 
PIDERMAL growth  factor (EGF) 1 is  a  small  protein 
that acts as a mitogen for various cell types bearing 
specific EGF receptors (reviewed in references 3 and 
21). The EGF receptor molecule is a glycoprotein of 170,000 
mol wt (3, 21) that is composed of three functional domains: 
an extracellular EGF-binding domain, a transmembrane re- 
gion, and a cytoplasmic kinase domain (26). EGF binds to 
randomly dispersed receptors that rapidly cluster in the re- 
gion of membrane coated pits and then becomes internal- 
ized, delivering the occupied receptors to lysosomes where 
both EGF and the receptor become degraded by proteolytic 
enzymes (3,  4,  21). The clustering and  internalization of 
EGF receptor complex on cultured cells are temperature- 
sensitive processes that are completely inhibited at 4°C. 
Comparison of the lateral and rotational diffusion of the 
EGF receptor indicates that the rotational diffusion of the 
EGF receptor is controlled by the viscosity of the lipid ma- 
trix (30), whereas the lateral diffusion of the EGF receptor 
seems to be limited by interactions in addition to viscous 
drag (ll). The lateral diffusion of EGF receptor in the mem- 
brane of human A-431 cells and mouse 3T3 cells is 1.5-0.3 
x  10  -l° cm2/s (ll, 21). This value is similar to the diffusion 
coefficient measured for many membrane proteins (reviewed 
in  references  14 and 22).  The additional  interactions that 
limit the lateral diffusion of EGF receptor specifically as well 
as many other membrane proteins, in general, could be due 
to interactions with the underlying cytoskeletal network, in- 
teractions  with  other  membrane  proteins,  or  interactions 
with the extracellular matrix. 
I.  Abbreviations  used in  this  paper:  DME,  Dulbecco's modified Eagle's 
medium; EGF, epidermal growth factor; FPR, fluorescence photobleaching 
recovery; Rh-EGF, rhodamine-EGF; SV-40, simian virus 40. 
In this study we compare the lateral diffusion of various 
EGF  receptor mutants  with  increasing  deletions  in  their 
carboxy-terminal cytoplasmic kinase domain composed of 
542 amino acids (26). A  full-sized cDNA construct of the 
EGF  receptor and  different deletion  constructs  were  ex- 
pressed in monkey COS cells. The COS cells are CV-1 mon- 
key kidney cells transformed by a simian virus 40 (SV-40) 
genome defective in the origin of replication (10). Since COS 
ceils constitutively express the large T antigen, transfected 
plasmids containing an SV-40  origin can replicate to high 
copy numbers and yield high amounts of protein. 
The study of lateral mobilities in the COS cell system has 
been advantageous  since:  (a)  Analysis is fast and protein 
products can be analyzed 2-3 d after transfections. (b) The 
COS cells express large quantities of EGF receptor and its 
mutants. Moreover, similar amounts of receptor and its mu- 
tants are expressed in the transfected cells. This is in contrast 
to stable cell lines obtained by transfection, which usually 
express variable amounts of protein products. (c) The lateral 
diffusion coefficients of  the EGF receptor and its various mu- 
tants labeled with rhodamine EGF (Rh-EGF) are measured 
using the fluorescence photobleaching recovery (FPR) meth- 
od (reviewed in references 14 and 22). In FPR, individual 
cells are analyzed; therefore, the fact that only 5-10% of the 
COS  cells express the various EGF receptor cDNA con- 
structs is not a limitation. 
Our results show that large deletions in the cytoplasmic 
domain of the EGF receptor do not affect its lateral mobility 
and even a  mutant that has only nine amino  acids  in the 
cytoplasmic domain still translates with an apparent diffu- 
sion coefficient of D  ---  1.5  x  10  -~ cm2/s.  It is concluded 
that most of the cytoplasmic domain of EGF receptor, in- 
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various  phosphorylation  sites,  are  not required for the re- 
striction of the lateral  mobility of the EGF receptor. 
Materials and Methods 
Cells 
Monkey COS cell (10) clone M6, kindly provided by M. Horowitz (Weiz- 
mann Institute), and human A-431 cells were grown in Dulbecco's modified 
Eagle's medium (DME) containing  10%  fetal  calf serum,  supplemented 
with penicillin-streptomycin. For microscopic studies, the cells were grown 
on glass coverslips in 35- or 100-mm  tissue culture dishes. 
Recombinant Plasmids 
The full length cDNA was pieced together from overlapping lambda phage 
cDNA clones kHER-A64 and ~,HER-A21 (26) and subeloned into PBR322. 
The final subclone extended from the SstI site, 15 base pairs (bp) before the 
initiation codon for translation (nucleotide 171 according to Ullrich et al. 
[26]), to an XmnI site 151 bp after the termination codon (nucleotide 3,970). 
Synthetic Xhol linkers DNA were used to convert both ends to Xhol sites 
and were then subcloned into the Pvu II site of PBR322 that was changed 
similarly to an XhoI site. The EGF receptor cDNA with XhoI ends was then 
placed into an early substitution SV-40 based expression vector. This vector 
is similar to pLSV (17) except that a polylinker containing a BglII and an 
SmaI site was introduced between the HindIII and the BclI sites. This plas- 
mid was generously provided by O. Laub (Weizmann Institute). The SmaI 
site was changed to an XhoI site and was used for cloning the plasmid, The 
final plasmid in the correct orientation denoted as pLSX is diagrammed in 
Fig.  1. 
The plasmid pLSXC was constrticted from the plasmid pLSX. pLSX was 
digested with HincII, and Xhol linkers were added to the fragments. Excess 
digestion with XhoI released a 3.6-kb  fragment that, after gel purification, 
was ligated into the Xhol site of the vector. 
The plasmid pLAB71 was constructed by partial digestion of pLSX with 
Ball. XbaI DNA linkers were added, and excess linkers were removed by 
digestion with XbaI followed by agarose gel electrophoresis. Purified frag- 
ments were self ligated to close the circle. 
The  plasmid pLANA8  was  constructed  from  the  pLABT1 plasmid. 
pLAB71  was digested by Narl and the staggered ends were filled in with a 
Klenow fragment of DNA polymerase I.  The blunt-ended fragment was 
ligated with a synthetic 26-bp double-stranded oligonucleotide composed of 
18 bp representing sequence 2,199-2,217  of the EGF receptor attached to 
a  7-bp sequence containing the XbaI site, with the following sequence: 
5 '-C  CACATCGTTCGGAAGCCTCTAGAG -3'. 
The ligated fragment was cleaved by SmaI and excess XbaI and was 
purified by gel electrophoresis. This 1.2-kb fragment was further ligated to 
an 8-kb SmaI-XbaI fragment, which was recovered from pLSX. 
Each of the plasmids constructed was used to transform E. coli HB101, 
and the plasmids containing the cDNA constructs were tested for the pres- 
ence of the desired deletions by digestion with appropriate restriction en- 
donucleases. Enzymes were provided by New England Biolabs (Beverly, 
MA)  and  Boehringer-Mannheim  Biochemicals  (Indianapolis,  IN)  and 
were used as described by the manufacturers. 
Transfection of COS Cells and Analysis 
of  Expressed cDNA Constructs 
Transfection experiments were performed according to the DEAE-dextran 
procedure as described by Sompayrac and Donna (24) with some modifica- 
tions. COS cells from a confluent tissue culture dish were split (1:5) 2 d be- 
fore  transfection into  tissue  culture  dishes containing  glass  coverslips. 
Shortly before transfection, the cells were washed with DME and incubated 
with 5 ml of DME containing 50 mM Tris-chloride (pH 7.3),  0.2 mg of 
DEAE-dextran per ml (2  x  10 mol wt, Pharmacia Fine Chemicals, Pis- 
cataway,  NJ),  and  10  lag of plasmid DNA.  After 6-8  h,  the cells were 
washed extensively and DME containing 10% fetal calf serum was added. 
The cells were analyzed for the expression oftbe various EGF receptor con- 
structs, 48-72 h after transfection. Cells were labeled with [3SS]methionine 
(50 laCi/ml)  in methionine-free DME for 4-5 h, and cell extracts were pre- 
pared as previously described (16). Specific antibodies against EGF receptor 
coupled to Sepharose-protein A were used to immunoprecipitate the EGF 
receptor protein and its various deleted forms. The samples were analyzed 
by gel electrophoresis on a 5-10% polyacrylamide gel containing SDS. The 
gels were treated with Amplify for 30 min, dried, and exposed for 18 h at 
-70°C  for  autoradiography.  The  autophosphorylation reaction  of EGF 
receptor and its various mutants was performed according to the procedure 
described by Kris et al,  (16). 
The antisera that were used are as follows:  RK-2 is a rabbit antiserum 
against a  synthetic peptide from the carboxy4erminal region of the EGF 
receptor (16). Anti-Al is a  rabbit antiserum prepared against A-431 cell 
membranes and reacts predominantly with the extracellular domain of the 
EGF receptor (29). 
FPR 
The lateral  diffusion coefficient of the fluorescently labeled EGF receptor 
was measured by the FPR method (reviewed in references 14 and 22).  In 
FPR, a small region on the cell surface is illuminated with a focussed attenu- 
ated laser beam (argon, 514 nm). Then, a brief (",,100 ms) intense laser pulse 
irreversibly bleached the illuminated region, and the time course of recovery 
of fluorescence in the bleached region due to replenishment by unbleached 
fluorophores from adjacent regions on the cell surface was recorded. The 
fluorescence recovery curves were fitted to the full  series solution of the 
diffusion equation (1) by a computer program that used a nonlinear least 
squares fitting procedure to estimate the best values for the lateral diffusion 
coefficient (/9, cm2/s) and the fraction of mobile labeled molecules on the 
cell surface (R%) (19). All measurements were performed at room temper- 
ature. 
Results 
Various constructs of the EGF receptor cDNA with increas- 
ing  deletions at the 3' coding region of the EGF receptor 
cDNA were prepared. The SV-40 early promoter was used 
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Figure 1.  Structure of EGF receptor expression construct and mu- 
tants. (a) The structure of plasmid pLSX is shown in the right orien- 
tation.  Thin  line,  PBR322  sequences;  stippled  bars,  SV-40  se- 
quences; and striped bar, EGF-receptor sequences. Ori, the SV-40 
origin of replication. Arrow, the direction of transcription initiating 
at the SV-40 early promoter. (b) The structure of the coding region 
of the various EGF receptor mutants. Plasmids were constructed as 
described in the text. The signal sequence, the transmembrane do- 
main, and the kinase domain are indicated. The amino acid num- 
bering is as described in reference 26.  Black arrows,  positions of 
the tyrosine phosphorylation sites. (Thr 654) Open arrows, threo- 
nine phosphorylation sites. 
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tants expressed  in the  COS ceils.  Subconfluent cells growing  in 
10-cm dishes transfected with 10 ltg per dish of  the various plasmids 
using the DEAE-dextran procedure.  Control cells were transfected 
with 10 Ixg of the same plasmid containing the dihyrofolate reduc- 
tase coding sequence, or were mock transfected. The cells were la- 
beled for 4 h, then solubilized and immunoprecipitated as described 
in Materials and Methods. Equal amounts of TCA-insoluble radio- 
activity were reacted with antibody anti-AI. Anti-AI is directed pri- 
marily against extracellular sequences of  the EGF receptor. The po- 
sitions of known molecular  weight markers are indicated on the 
right in kilodaltons. 
to  transiently  express the various constructs  in  COS  cells 
(25). Fig. 1 shows the structure of the various constructs that 
were used in this study.  (a) pLSX.  This construct encodes 
the entire EGF receptor (I in Fig.  1 b). (b) pLSXC. A dele- 
tion of 63 amino acids at the carboxy tail terminating at resi- 
due  1,123 yields  a  receptor  mutant  devoid  of  two  au- 
tophosphorylation sites (H in Fig.  1 b). (c) pLAB71. A large 
deletion at the cytoplasmic domain yields a receptor mutant 
devoid of most of the tyrosine kinase domain possessing 98 
cytoplasmic amino acids (llIin Fig. 1 b). (d) pLANA8. This 
construct  encodes  an  EGF  receptor  mutant  with  a  small 
cytoplasmic region of nine amino acids terminating in resi- 
due 653. This mutant is devoid of Thr 654 which is the major 
kinase C  phosphorylation site (/V in Fig.  1 b). 
To analyze the sizes of the proteins expressed by the vari- 
ous  EGF  receptor cDNA  constructs,  the  transfected COS 
cells were metabolically labeled with  [35S]methionine  and 
then subjected to immunoprecipitation experiments with an- 
tibodies directed against the extracellular portion of the EGF 
Figure 3. Analysis of the kinase 
activity  of the  EGF  receptor 
mutants expressed in COS cells. 
Transfected cells  were  solubi- 
lized and treated with 5 ~tg/ml 
EGF or with buffer alone for 20 
min  on  ice.  RK-2  antiserum 
was used to precipitate the EGF 
receptor.  The  immunoprecipi- 
tated  receptor  was  incubated 
with  [),-32p]ATP in a standard 
autophosphorylation  assay  as 
described  in  Materials  and 
Methods.  The phosphorylated 
products were analyzed by 7.5 % 
SDS PAGE followed by autora- 
diography. The position of 170 
kD  is  shown,  as  determined 
from known markers. 
receptor AgAI. Fig. 2 shows an autoradiogram of SDS PAGE 
analysis  of the  immunoprecipitated polypeptides.  Control 
experiments (Fig. 2) indicate that the COS cells express en- 
dogenous EGF receptors. From quantitative binding experi- 
ments with ~25I-EGF, it is concluded that the COS cells ex- 
press •50,000  receptors per cell. The cells transfected with 
the various constructs express, in addition to the endogenous 
receptor, large quantities of the human EGF receptor and its 
various mutants (Fig. 2).  The pLSX construct,  which con- 
tains the entire coding region of the EGF receptor, appears 
as a polypeptide of 170,000 D. pLSXC, which has a deletion 
of 63 amino acids at the carboxy terminal, encodes a poly- 
peptide of similar apparent molecular weight as revealed by 
this gel system. The pLAB71 construct encodes a polypep- 
tide of 115,000 D, and the pLANA8 construct encodes a poly- 
peptide of 105-110 kD.  Note that  *35,000  of the apparent 
molecular weight of the various EGF receptor mutants is due 
to  the  carbohydrates that  are  attached  to the  extracellular 
EGF-binding domain of the EGF receptor molecule (21, 26). 
The EGF receptor expressed in COS cells by the pLSX 
construct binds EGF, and its intrinsic protein tyrosine kinase 
activity (27)  can be enhanced several folds in the presence 
of the growth factor leading to autophosphorylation (Fig. 3). 
The carboxy terminus-deleted  construct,  pLSXC,  lacking 
two  autophosphorylation  sites  (7),  can  still  be  autophos- 
phorylated in the presence of EGF to some extent, probably 
by using other autophosphorylation sites. 
After 48-72  h  the transfected cells were incubated with 
Rh-EGF to detect cells that express the various EGF receptor 
mutants on their cell surface. Note that the COS cells express 
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of receptors can be barely visualized after the cells were la- 
beled with Rh-EGF and is much lower than the fluorescent 
labeling of the COS cells that express the various EGF re- 
ceptor constructs.  Quantitative fluorescence measurements 
using the photomultiplier system of the FPR apparatus indi- 
cate that the COS cells that express the various EGF recep- 
tors mutants possess 50-100-fold more binding sites for Rh- 
EGF than the untransfected COS cells (Table I). As previ- 
ously observed for the COS system, only 5-10% of the cells 
express large quantities of the various constructs (24). 
The lateral diffusion of the various EGF receptor mutants 
expressed in the COS cells and labeled with Rh-EGF was 
measured by the FPR method (14, 22).  The intensity of the 
fluorescence of Rh-EGF bound to the cells that bear the vari- 
ous EGF receptor mutants was similar (Table I), indicating 
that these mutants are expressed to similar levels on the cell 
surface. Table II summarizes the lateral diffusion coefficients 
of the various EGF receptor mutants. It appears that all the 
EGF receptor mutants translate in the membrane of the COS 
Cells with a similar diffusion coefficient of D  --- 1.5  x  10  -~° 
cmVs at room temperature. The mobile fraction of the vari- 
ous mutants is also similar in the range of R%  =  50-80%. 
A  similar value of D  was  measured for EGF receptor in 
A-431  cells  at  room temperature.  Table II also  gives the 
lateral diffusion of the fluorescent lipid probe nitrobenzox- 
adiazole-phosphatidylethanolamine in the membrane of the 
COS  cells.  D  lipid  probe  =  4.4  ×  10  -9  cm2/s,  a  value 
similar to the diffusion coefficient of lipid probes measured 
in many cultured cells. 
Discussion 
The pleiotropic effects of EGF are mediated by the  EGF 
receptor. The EGF receptor possesses intrinsic protein tyro- 
sine kinase activity, which is regulated by the binding of EGF 
to the extracellular binding domain (3, 27). The EGF recep- 
tor kinase phosphorylates various  cellular proteins and at 
least three tyrosine residues,  which are located at the car- 
boxy-terminal end of the EGF receptor itself (7). Moreover, 
kinase C activated by the tumor promoter ester 12-O-tetra- 
decanoyl phorbol-13-acetate (TPA) phosphorylates Thr 654 
(6,  12) of the receptor molecule, a residue located 10 amino 
acids in the cytoplasmic domain of the EGF receptor. Since 
TPA reduces the affinity of the receptor towards EGF (15, 23) 
Table I. Quantitative Measurements of  Fluorescence 
Intensity of COS Cells That Express EGF Receptor Mutants 
Cell type and construct  Fluorescence  in- 
tensity 
pLSX construct in COS 
pLSXC construct in COS 
pLAB71  construct in COS 
pLANA8 construct in COS 
Untransfectexi COS cells 
A-431 cells 
counts/s per 1  I~m  2 
5,000  4-  1,500 
4,500  4-  1,500 
5,500  +  1,800 
3,000  5-  1,100 
60+  15 
900  ±  150 
All fluorescence measurements were performed  with a laser beam (200 roW) 
attenuated 1/20,000. The various cells were labeled with Rh-EGF as described 
in Materials and Methods, and the fluorescence intensity was measured using 
the photomultiplier  systems of the FPR apparatus.  Values represent  mean  + 
SD. 
and its tyrosine kinase activity (5,  13), it was proposed that 
the phosphorylation of Thr 654 may regulate these functions 
(6, 12). TPA also effects the internalization of the EGF recep- 
tor and therefore it is possible that the phosphorylation state 
of the receptor could play a role in its endocytic routing (2). 
In this study we compare the effect of various deletions in 
the cytoplasmic kinase domain of the receptor on its dynamic 
properties.  Our results  show that all the mutants translate 
in  the  plane  of  the  membrane  with  a  similar  diffusion 
coefficient, even though the truncations effected endocytosis 
drastically (18). 2 The degree of endocytosis of the pLSXC 
construct encoding a receptor with kinase activity but with- 
out two autophosphorylation sites is comparable to the full 
receptor. The EGF receptor mutant pLAB71 is devoid of ki- 
nase activity, and pLANA8 is further deleted to yield a mu- 
tant without Thr 654.  Both mutants internalize weakly into 
COS and Chinese hamster ovary cells (18). Interestingly the 
pLANA8 mutant, which has a cytoplasmic tail of only nine 
amino acids, diffuses with a similar diffusion coefficient as 
the "wild-type" receptor, which has a complete cytoplasmic 
domain of 542 amino acids with intrinsic enzymatic activity 
and various regulatory sites. A  similar diffusion coefficient 
was measured for the membrane IgG of lymphocytes (D = 
2  x  10  -~° cm:/s) (8),  which possesses only three cytoplas- 
mic amino acids.  Furthermore,  deletion of most of the 31 
cytoplasmic residues of H-2L  d antigen did not affect either 
its  lateral  diffusion  coefficient  or  the  amount  of mobile 
molecules in the plane of the membrane (9). 
We have expressed these and other constructs in CHO cells 
(18),  which are devoid of EGF receptors, and similar con- 
structs  in  NIH-3T3  cells, 2 and  studied  their  capacity  to 
undergo  receptor-mediated endocytosis.  We have obtained 
several endocytosis-defective mutants that are mutated in the 
cytoplasmic domain of the receptor. These include the prod- 
ucts of pLABT1  and pLANA8 constructs.  However, other 
receptor constructs mutated in the cytoplasmic domain that 
Table II. Diffusion Coefficients and Mobile Fractions 
of  EGF Receptor Mutants 
Cell type and  No. of 
construct  samples  Diffusion, cm2/s  % Mobility 
pLSX construct in 
COS  26  1.2 +  0.7  x  10  -1°  61  +  21 
pLSXC construct in 
COS  29  1.6  +  1.4  x  10  -~°  59 +  21 
pLAB71 in COS  23  1.5  5- 0.77  x  10  -]°  70 5-  18 
pLANA8 in COS  27  1.2  5- 0.7  ×  10  -1°  77  5- 21 
NBD-PE in COS  37  4.4  5- 2.1  ×  10  -9  78  5-  18 
Rh-EGF A-431  15  2.3  +  1.3  x  10  -l°  49 5-  19 
NBD-PE A-431  26  1.6  5- 0.7  x  10  -9  84 5-  12 
All  diffusion  measurements  were done  at  room temperature  (beam  radius, 
0.699  I~m). The  spread  in the diffusion constant  could be circumvented  by 
separation of each measurement into slow and fast diffusing populations. How- 
ever,  histograms  of each of the diffusion coefficient of each  mutant did not 
separate into two such populations nor were any trends found between the mo- 
bility of the constructs when an arbitrary 20% of the samples were chosen for 
the slow diffusion population.  The diffusion coefficients and percent mobility 
values are represented as mean  +  SD. 250 ng/ml Rh-EGF added to cells for 
1 h  at 4°C.  20  I~l/1,000 I~1  nitrobenzoxadiazole-phosphatidylethanolamine 
(NBD-PE) (gift from M, Shinitsky, Weizrnann Institute) was added to cells for 
1 h at 4°C. Beam radius for lipid probe measurements equals  1.54 Ixm. 
2. Prywes, P., E. Livneh, A. Ullrich, and J. Schlessinger.  Manuscript sub- 
mitted  for publication. 
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that the kinase activity per se may not be required for en- 
docytosis. 2  We  are  currently  analyzing  more  constructs 
with mutations in the cytoplasmic region to better define the 
sequences that control the endocytosis of EGF receptor. 
Clearly a  deletion of 533  amino acid residues  from the 
cytoplasmic  domain  of  EGF  receptor  does  not  affect  its 
lateral mobility. Hence, most of the cytoplasmic domain of 
EGF  receptor may not interact with the underlaying cyto- 
skeletal network, and it does not restrict receptor diffusion 
by "steric hindrance: However, it is possible that the small 
cytoplasmic  tail  of nine  amino  acids  that  remains  in  the 
pLANA8 mutant can already interact with the underlaying 
cytoskeleton. At least three additional mechanisms (9) may 
be relevant for the regulation of the lateral diffusion of the 
EGF receptor.  (a) The concentration of the proteins in the 
plasma membrane is high, thus possibly providing an addi- 
tional constraint on receptor mobility. (b) The EGF receptor 
may  interact  with  another  membrane  protein  that  is  as- 
sociated  with  the cytoskeleton.  (c)  It  is  possible  that the 
lateral mobility of EGF receptor is hindered by dominant in- 
teractions  between  the  extracellular  domain  of  the  EGF 
receptor  and the glycocalyx.  These  three hypotheses may 
also  explain  the  constrained  lateral  diffusion  (D  =  3  x 
10  -1° cm2/s)  of steroyl dextrans incorporated in the plasma 
membrane  of animal  cells  in  culture  (28).  Whatever  the 
mechanism, it is clear that a deletion of most of the cytoplas- 
mic  domain of EGF  receptor,  which  leads  to  the loss  of 
several functional sites, is not required for the restriction of 
the lateral mobility of the EGF receptor kinase. 
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